Selvita (WAR:SLV) Debt-to-EBITDA : 0.74 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Selvita Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Selvita's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was zł46.9 Mil. Selvita's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was zł177.9 Mil. Selvita's annualized EBITDA for the quarter that ended in Dec. 2023 was zł304.6 Mil. Selvita's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.74.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Selvita's Debt-to-EBITDA or its related term are showing as below:

WAR:SLV' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.1 Med: 1.53 Max: 4.05
Current: 1.72

During the past 9 years, the highest Debt-to-EBITDA Ratio of Selvita was 4.05. The lowest was 0.10. And the median was 1.53.

WAR:SLV's Debt-to-EBITDA is ranked better than
53.33% of 105 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96 vs WAR:SLV: 1.72

Selvita Debt-to-EBITDA Historical Data

The historical data trend for Selvita's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Selvita Debt-to-EBITDA Chart

Selvita Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

N/A

1.25

3.43

2.80

1.81

Selvita Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial															1.99	3.79	2.44	3.57	0.74

Competitive Comparison of Selvita's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Selvita's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Selvita's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Selvita's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Selvita's Debt-to-EBITDA falls into.

Selvita Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Selvita's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(46.893	+	177.852)	/	124.339
	=	1.81

Selvita's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(46.893	+	177.852)	/	304.592
	=	0.74

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Selvita (WAR:SLV) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Selvita Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Selvita's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Selvita (WAR:SLV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Selvita SA (WAR:SLV) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bobrzynskiego 14, Park Life Science, Krakow, POL, 30-348

Website

https://www.selvita.com

Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.